Coastal Infusion Administers Zemaira®
| J-Code | J0256 |
|---|---|
| Manufacturer | CSL Behring |
| First Approved | 07/08/2003 |
Coastal Infusion can administer your Zemaira prescription at any of our south Florida locations.
Zemaira (alpha-1 proteinase inhibitor) is a peptide isolated from donor plasma and purified. It is used to treat emphysema caused by severe Alpha-1 Antitrypsin (AAT) deficiency, a rare genetic disorder that can cause lung and liver damage.
The alpha-1 protein circulates in the bloodstream and works to protect the lungs from inflammation due to infection or inhaled irritants, such as tobacco smoke.
Zemaira is not a cure for alpha-1 antitrypsin deficiency, and it does not prevent the progression of the disease. However, it can help slow down the rate of lung function decline, improve lung function, and reduce the risk of lung infections.
What It Treats
Zemaira is used to treat emphysema due to alpha-1 proteinase inhibitor deficiency.
Prescribed By
Zemaira is most often prescribed by Pulmonologists.
How it’s Administered
Zemaira is administered by intravenous infusion. Zemaira infusions take about 30 minutes.
Frequency
Zemaira is generally administered weekly.
Related Drugs
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies